SCP
AZN icon

Sivia Capital Partners’s AstraZeneca AZN Stock Holding History

Sivia Capital Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Hold
1,646
– – 0.04% 446
2026
Q1 		$325K Sell
1,646
-2,352
-59% -$454K 0.06% 340
2025
Q4 		$735K Buy
3,998
+568
+17% +$99.6K 0.15% 175
2025
Q3 		$526K Sell
3,430
-187
-5% -$28.3K 0.15% 151
2025
Q2 		$505K Buy
3,617
+11
+0.3% +$1.54K 0.17% 123
2025
Q1 		$530K Sell
3,606
-89
-2% -$12.9K 0.25% 66
2024
Q4 		$484K Buy
3,695
+113
+3% +$15.8K 0.24% 60
2024
Q3 		$558K Buy
3,582
+243
+7% +$39.2K 0.33% 50
2024
Q2 		$521K Buy
3,339
+517
+18% +$77.8K 0.35% 48
2024
Q1 		$382K Buy
2,822
+520
+23% +$68.9K 0.26% 71
2023
Q4 		$310K Buy
+2,302
New +$299K 0.24% 85

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Sivia Capital Partners's AZN Position: Q2 2026 in Review

Sivia Capital Partners held its AstraZeneca (AZN) position steady in Q2 2026 at 1,646 shares worth $312K. The position accounts for 0.04% of the portfolio, ranked #446.

Sivia Capital Partners first reported a position in AZN in Q4 2023 and has held it in 11 quarters since. The position peaked at $735K in Q4 2025. 438 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Sivia Capital Partners held 1,646 shares of AstraZeneca worth $312K as of Q2 2026.
  • Sivia Capital Partners left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.04% of Sivia Capital Partners's portfolio in Q2 2026, its #446 holding.
  • Sivia Capital Partners first reported a position in AstraZeneca in Q4 2023 and has held it in 11 quarters since.
  • Sivia Capital Partners's AstraZeneca position peaked at $735K in Q4 2025.
  • 438 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.